The proportion of patients with vasculitis and rapidly progressive nephritis aged 70 years or over has risen from about 10% in the 1980s to over 30% in series reported in the 1990s. This study was undertaken to examine the presentation and outcome of such older patients. Seventeen of 56 patients (30%) who presented at two renal units were aged 70 years or over. Mean creatinine level at presentation was 530 ytmol/l, and five patients received dialysis at presentation. Outcome was dependent on three factors, namely comorbid pathology, response to immunosuppressive therapy, and the occurrence in three cases of temporary spontaneous partial remission. Overall patient survival at one and two years was 62.5% and 50%, respectively, and 90% and 100% of surviving patients were independent of dialysis at one and two years, respectively. Response to chemotherapy was excellent, with full rehabilitation in many cases and no deaths directly attributable to adverse effects of immunosuppressive therapy. We conclude that diagnosis ofvasculitis and rapidly progressive glomerulonephritis by renal biopsy and the subsequent administration of chemotherapy (including cyclophosphamide in many cases) resulted in a worthwhile benefit in these elderly patients.
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Keywords: vasculitis, glomerulonephritis, cyclophosphamide, elderly patients It is increasingly recognised that rapidly progressive glomerulonephritis with vasculitis occurs in elderly patients. In three British series published in the mid 1980s, only 15 of 132 patients (I 1 %) were aged over 70 years,'"3 and in some series no patient was aged over 70 years. 4 TREATMENT AND OUTCOME Table 2 shows induction immunosuppression given in the first three months, together with outcome at three months and latest follow-up. Actual patient survival is shown in the figure. Three patients (18%) had a spontaneous partial remission with improvement in renal Immunofluorescence showed that six patients had a 'pauci-immune' glomerulonephritis, and there was a variety of patterns of immunoglobulin and complement deposition in the other biopsies (table 1).
Discussion
The increased proportion of elderly patients with crescentic glomerulonephritis and progressive renal failure compared with reports from the 1980s could reflect either a higher incidence of disease or an increased rate of diagnosis, we suspect the latter. This may be due to an increased referral rate of elderly patients to renal units, and also to the wider availability of the ANCA test to screen patients with renal failure for vasculitis.1 PRESENTATION These elderly patients had evidence of multisystem vasculitis in the majority of cases, and the majority also had a positive ANCA test. Both these features were similar to the younger cases in this series, and to previous reports in the literature."3,2'"3 Screening for the presence of multisystem vasculitis can be performed simply by testing the urine for blood (all patients in this series were dipstick positive for blood in the urine), measuring renal function and testing for ANCA. However, it should be noted that ANCA are not always present, even in patients with active multisystem or pulmonary disease. There was a high incidence of pulmonary vasculitis in these elderly patients, with either pulmonary haemorrhage or fibrosis. The possibility ofvasculitis should therefore be addressed carefully in any patient with haemoptysis or unexplained abnormality in the lungs.
CO-MORBID DISEASE AND OUTCOME Co-morbid disease caused more deaths than vasculitis in this series, although in many cases this was because co-morbid disease determined a patient's suitability for renal replacement therapy. It should be remembered when assessing such patients that some apparently comorbid conditions (such as arthritis, breathlessness or cerbrovascular disease) could be due to multisystem vasculitis, and thus potentially respond well to treatment.
SPONTANEOUS PARTIAL REMISSION
It is increasingly recognised that most cases of systemic vasculitis with renal involvement run a chronic course, and relapse with worsening of renal failure may occur even after many years of follow-up."4 However, we observed three cases in this series with a spontaneous improvement Differential diagnoses in acute kidney failure * rapidly progressive glomerulonephritis * acute tubular necrosis with associated sepsis * bacterial endocarditis * acute interstitial nephritis * multiple myeloma * cholesterol embolisation Importantly, all four patients with a spontaneous partial remission subsequently experienced a decline in renal function, with two reaching end-stage renal failure. This may have been due to low-grade disease activity, or to progressive tubular atrophy in scarred kidneys. Long-term follow-up is therefore essential in patients who have apparently improved spontaneously, with continual monitoring of disease activity and renal function.
IMMUNOSUPPRESSIVE TREATMENT
The response to induction immunosuppression in these patients was excellent, with good medium-term preservation of renal function in surviving patients (table 2) . Furthermore, there were no serious side-effects from immunosuppressive therapy, although the steroid dosage was tapered more rapidly than is our normal practice in younger patients. Furthermore the course of pulse intravenous cyclophosphamide was shorter and given at a lower dose than in younger patients.
Although there may be reservations about the use of powerful cytotoxic drugs in the elderly, it has clearly been shown that prednisolone alone is generally ineffective in the treatment of Wegener's granulomatosis with renal failure, and the same probably applies for other types of systemic vasculitis with necrotising or crescentic glomerulonephritis.13"15
Therefore we believe that cyclophosphamide should be used in patients with active renal involvement, whatever their age.
Although a diagnosis of vasculitis with renal failure may be probable on clinical grounds, it is our practice to perform renal biopsy in all Summaryllearning points * 30% of renal vasculitis cases are over 70 years * renal biopsy is required for diagnosis * treatment response may be excellent, even in the elderly * rapid diagnosis improves outcome cases before giving cyclosphosphamide. Thus we can confirm the diagnosis and determine the degree of scarring in the kidney and hence the likely benefit from intensive immunosuppressive therapy. It has previously been suggested that patients presenting with advanced renal failure have a particularly poor outcome.7"6 However, in this series the renal biopsy appearances provided a better indication of prognosis than the presenting creatinine level.
DIALYSIS
In this series nine of the 17 elderly patients developed renal failure to a degree such that dialysis was necessary for relief of symptoms. Only three cases were unsuitable for dialysis because of co-morbid pathology. In the other six cases, three patients required dialysis at presentation but later recovered renal function, and two patients were successfully treated with outpatient maintenance dialyses. One patient who required dialyses at presentation died soon after from acute gastrointestinal haemorrhage.
We conclude that, even in elderly patients, dialysis may result in a successful outcome and patients should be referred to a specialised unit for assessment when renal failure is present.
Summary
In conclusion, it seems that the improvement in outcome for patients with systemic vasculitis first noted in the 1980s for younger patients'0 can now be applied to the elderly. Intensive treatment including renal biopsy, dialysis and cyclophosphamide treatment can be used successfully in many such cases.
